Edition:
United Kingdom

Cascadian Therapeutics Inc (CASC.OQ)

CASC.OQ on NASDAQ Stock Exchange Global Select Market

4.27USD
19 Jan 2018
Change (% chg)

$0.10 (+2.40%)
Prev Close
$4.17
Open
$4.17
Day's High
$4.38
Day's Low
$4.17
Volume
64,987
Avg. Vol
88,259
52-wk High
$4.97
52-wk Low
$3.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.279
Jun '17 0.00 -0.299
Mar '17 0.00 -0.298
FY 2016 Dec '16 0.00 -0.466
Sep '16 0.00 -0.522
Jun '16 0.00 -1.566
Mar '16 0.00 -0.814
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 6.25 25.00 0.00 8.33
Earnings (per share)
Quarter Ending Mar-18 2 -0.29 -0.28 -0.30 --
Quarter Ending Jun-18 2 -0.30 -0.30 -0.30 --
Year Ending Dec-18 4 -1.10 -0.69 -1.30 -2.04
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.70 32.90
P/E High - Last 5 Yrs. -- 302.09 46.03
P/E Low - Last 5 Yrs. -- 94.18 24.39
Beta 2.37 0.88 0.89
Price to Sales (TTM) -- 94.43 5.45
Price to Book (MRQ) 1.57 13.36 5.38
Price to Tangible Book (MRQ) 1.83 13.64 6.89
Price to Cash Flow (TTM) -- 72.87 23.43
% Owned Institutions 83.83 11.52 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.72 5.23
Payout Ratio(TTM) -- 16.22 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 401.22 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 71.05 5.44
Sales - 5 Yr. Growth Rate -- 33.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 80.92 29.49 19.33
EPS (TTM) vs TTM 1 Yr. Ago 51.25 -- --
EPS - 5 Yr. Growth Rate -- 40.21 10.77
Capital Spending - 5 Yr. Growth Rate 0.69 40.33 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 16.44 5.23 2.97
LT Debt to Equity (MRQ) 0.00 21.05 12.10
Total Debt to Equity (MRQ) 0.00 22.61 16.38
Interest Coverage (TTM) -- -102.06 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.21 54.76
Gross Margin - 5 Yr. Avg. -- 52.54 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -239.51 15.33
Operating Margin (TTM) -- -519.41 7.60
Operating Margin - 5 Yr. Avg. -- -256.70 10.79
Pre-Tax Margin (TTM) -- -494.96 8.38
Pre-Tax Margin - 5 Yr. Avg. -- -256.63 11.19
Net Profit Margin (TTM) -- -496.46 4.70
Net Profit Margin - 5 Yr. Avg. -- -259.85 7.50
Effective Tax Rate (TTM) -- 23.29 23.05
Effective Tax Rate - 5 Yr. Avg. -- 18.77 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,318,311 855,725,045
Net Income/Employee (TTM) -831,509 3,079,098 100,665,187
Receivable Turnover (TTM) -- 20.24 5.76
Inventory Turnover (TTM) -- 2.31 3.34
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -38.48 0.09 10.97
Return on Assets - 5 Yr. Avg. -41.06 0.51 12.39
Return on Investment (TTM) -40.76 3.19 14.40
Return on Investment - 5 Yr. Avg. -43.38 3.64 16.20
Return on Equity (TTM) -42.52 4.52 16.09
Return on Equity - 5 Yr. Avg. -48.33 8.98 17.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -54.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cascadian Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 22.28 18.07 84 48
13 Week 14.62 9.04 73 60
26 Week 13.14 4.54 68 70
52 Week -53.10 -60.25 15 47
YTD 1.86 -10.55 47 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.78%
# of Holders: 120
Total Shares Held: 41,346,753
3 Mo. Net Change: 87,060
# New Positions: 9
# Closed Positions: 0
# Increased Positions: 13
# Reduced Positions: 1
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.